Publications by authors named "Gary Doug Myers"
Front Immunol
February 2024
Article Synopsis
- The study investigates the use of mediports for administering CAR T cell therapy in patients with B-cell malignancies, aiming to establish standardized practices in this area due to previous concerns about effectiveness and safety.
- Data was collected from 34 medical centers, analyzing 504 CAR T cell infusions, making it one of the largest reports on this topic since CAR T cell commercialization began in 2017.
- Results showed that 85% of centers accepted mediports as standard practice, with no incidents of CAR T cell infiltration reported among the 184 patients infused via mediports, supporting their safe use in clinical settings.
